/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $601K · -3117.30% margin · -$16M FCF
The business is unprofitable at the operating level (-3117.30% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 5.4%, steady but not accelerating.
ROIC dropped from -610.31% to -10892.28%, capital efficiency is deteriorating. Negative free cash flow of -$16M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$601K
▲ +5.4% YoY
Net Income (TTM)
-$19M
▲ +8.0% YoY
Op. Margin
-3117.30%
▲ +897.6pp YoY
ROIC
-10892.28%
▼ -10282.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$16M
▲ +6.3% YoY
Op. Cash Flow (TTM)
-$16M
▲ +6.1% YoY
Net Debt
-$1M
Net Cash Position
Cash & Equiv.
$1M
5Y CAGR: +2.8%
Continue Research